Indivior Pharmaceuticals Inc INDV NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

72/100

5/7 Pass

SharesGrow Intrinsic Value

Il y a eu 48 transactions d'initiés récentes enregistrées pour Indivior Pharmaceuticals Inc (INDV), dont 25 achats et 5 ventes. Le total des achats d'initiés s'élève à $203.61K et le total des ventes d'initiés à RSU Award.

Les initiés notables ayant une activité récente comprennent Barry Patrick A, Ciaffoni Joseph, Burris Jeffrey W. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — INDV

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2028-06-02	Barry Patrick A	Chief Commercial Officer	Inconnu	130,312	-	-	-
2028-05-08	Ciaffoni Joseph	Chief Executive Officer	Inconnu	422,302	-	-	-
2028-03-07	Burris Jeffrey W	Chief Legal Officer	Inconnu	71,743	-	-	-
2028-03-07	Anderson Woodrow D	Chief Accounting Officer	Inconnu	29,478	-	-	-
2028-03-07	Heidbreder Christian	Chief Scientific Officer	Inconnu	82,287	-	-	-
2028-03-07	Preblick Ryan	Chief Financial Officer	Inconnu	70,459	-	-	-
2026-03-14	Preblick Ryan	Chief Financial Officer	Exercice d'Options (Vente)	6,302	-	-	-
2026-03-13	Ryan Barbara	Director	Achat Informatif	8	$31.09	$248.68	5,724
2026-03-09	Ryan Barbara	Director	Achat Informatif	31	$32.56	$1.01K	5,716
2026-03-06	Kingsley Stuart A	Director	Achat Informatif	940	$31.87	$29.95K	5,582
2026-03-03	Burris Jeffrey W	Chief Legal Officer	Exercice d'Options (Vente)	104,300	-	-	-
2026-03-03	Anderson Woodrow D	Chief Accounting Officer	Exercice d'Options (Vente)	5,946	-	-	-
2026-03-03	Heidbreder Christian	Chief Scientific Officer	Exercice d'Options (Vente)	132,565	-	-	-
2026-03-03	Preblick Ryan	Chief Financial Officer	Exercice d'Options (Vente)	113,510	-	-	-
2026-02-10	Ciaffoni Joseph	Chief Executive Officer	Attribution de RSU	79,976	-	-	135,976
2026-02-10	Burris Jeffrey W	Chief Legal Officer	Attribution de RSU	26,897	-	-	27,657
2026-02-10	Barry Patrick A	Chief Commercial Officer	Attribution de RSU	31,380	-	-	31,380
2026-02-10	Anderson Woodrow D	Chief Accounting Officer	Attribution de RSU	6,903	-	-	11,293
2026-02-10	Heidbreder Christian	Chief Scientific Officer	Attribution de RSU	33,622	-	-	190,762
2026-02-10	Preblick Ryan	Chief Financial Officer	Attribution de RSU	37,358	-	-	317,940
2026-02-09	Burris Jeffrey W	Chief Legal Officer	Attribution de RSU	104,300	-	-	104,300
2026-02-09	Anderson Woodrow D	Chief Accounting Officer	Attribution de RSU	23,975	-	-	23,975
2026-02-09	Heidbreder Christian	Chief Scientific Officer	Attribution de RSU	132,565	-	-	132,565
2026-02-09	Preblick Ryan	Chief Financial Officer	Attribution de RSU	113,510	-	-	113,510
2026-01-26	Ninivaggi Daniel A	Director	Attribution de RSU	3,722	-	-	20,645
2026-01-26	Kingsley Stuart A	Director	Attribution de RSU	3,722	-	-	4,642
2026-01-26	Stejbach Mark	Director	Attribution de RSU	3,722	-	-	20,569
2026-01-26	Thompson Juliet	Director	Attribution de RSU	3,722	-	-	7,572
2026-01-26	Wheadon David E.	Director	Attribution de RSU	5,955	-	-	20,350
2026-01-26	Ryan Barbara	Director	Attribution de RSU	3,722	-	-	5,685
2026-01-26	Humphreys Keith	Director	Attribution de RSU	3,722	-	-	9,524
2026-01-05	Ninivaggi Daniel A	Director	Achat Informatif	775	$35.39	$27.43K	16,923
2026-01-05	Stejbach Mark	Director	Achat Informatif	775	$35.39	$27.43K	16,847
2026-01-05	Wheadon David E.	Director	Achat Informatif	1,771	$35.39	$62.68K	14,395
2026-01-05	Ryan Barbara	Director	Achat Informatif	775	$35.39	$27.43K	1,963
2026-01-05	Humphreys Keith	Director	Achat Informatif	775	$35.39	$27.43K	5,802
2026-01-01	Ninivaggi Daniel A	Director	Inconnu	-	-	-	16,148
2026-01-01	Kingsley Stuart A	Director	Inconnu	-	-	-	920
2026-01-01	Ciaffoni Joseph	Chief Executive Officer	Inconnu	1,266,903	-	-	-
2026-01-01	Burris Jeffrey W	Chief Legal Officer	Inconnu	-	-	-	760
2026-01-01	Stejbach Mark	Director	Inconnu	-	-	-	16,072
2026-01-01	Thompson Juliet	Director	Inconnu	-	-	-	3,850
2026-01-01	Wheadon David E.	Director	Inconnu	-	-	-	12,624
2026-01-01	Ryan Barbara	Director	Inconnu	-	-	-	1,188
2026-01-01	Anderson Woodrow D	Chief Accounting Officer	Inconnu	-	-	-	4,390
2026-01-01	Heidbreder Christian	Chief Scientific Officer	Inconnu	-	-	-	157,140
2026-01-01	Preblick Ryan	Chief Financial Officer	Inconnu	-	-	-	280,582
2026-01-01	Humphreys Keith	Director	Inconnu	-	-	-	5,027

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration